Healthcare provider profile · identity verified

Warren E Licht, MD

Internal Medicine · PROVIDENCE, RI · NPI 1447298641

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	674	176
Atorvastatin Calcium	Atorvastatin Calcium	557	141
Amlodipine Besylate	Amlodipine Besylate	446	118
Omeprazole	Omeprazole	419	121
Losartan Potassium	Losartan Potassium	411	114
Lisinopril	Lisinopril	404	112
Levothyroxine Sodium	Levothyroxine Sodium	276	71
Eliquis	Apixaban	256	41
Hydrochlorothiazide	Hydrochlorothiazide	219	63
Furosemide	Furosemide	195	60
Atenolol	Atenolol	169	43
Tamsulosin Hcl	Tamsulosin Hcl	160	43
Allopurinol	Allopurinol	156	36
Meloxicam	Meloxicam	156	40
Fluticasone Propionate	Fluticasone Propionate	150	66
Gabapentin	Gabapentin	145	42
Trazodone Hcl	Trazodone Hcl	144	44
Metformin Hcl Er	Metformin Hcl	143	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	23
Metoprolol Succinate	Metoprolol Succinate	139	39
Famotidine	Famotidine	129	40
Ezetimibe	Ezetimibe	126	40
Citalopram Hbr	Citalopram Hydrobromide	121	28
Clonazepam	Clonazepam	114	19
Montelukast Sodium	Montelukast Sodium	112	28
Simvastatin	Simvastatin	108	31
Metoprolol Tartrate	Metoprolol Tartrate	107	28
Albuterol Sulfate Hfa	Albuterol Sulfate	105	39
Metformin Hcl	Metformin Hcl	99	25
Pantoprazole Sodium	Pantoprazole Sodium	95	30
Mirtazapine	Mirtazapine	88	26
Sertraline Hcl	Sertraline Hcl	88	27
Ozempic	Semaglutide	86	16
Alprazolam	Alprazolam	83	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	82	suppressed
Carvedilol	Carvedilol	77	24
Lorazepam	Lorazepam	75	32
Jardiance	Empagliflozin	73	14
Xarelto	Rivaroxaban	72	12
Escitalopram Oxalate	Escitalopram Oxalate	71	20
Finasteride	Finasteride	70	19
Glimepiride	Glimepiride	70	21
Potassium Chloride	Potassium Chloride	66	16
Pravastatin Sodium	Pravastatin Sodium	60	19
Clopidogrel	Clopidogrel Bisulfate	55	14
Tizanidine Hcl	Tizanidine Hcl	55	23
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	53	suppressed
Bupropion Hcl Sr	Bupropion Hcl	51	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	19
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	40
Oxycodone Hcl	Oxycodone Hcl	47	11
Duloxetine Hcl	Duloxetine Hcl	46	13
Alendronate Sodium	Alendronate Sodium	45	17
Chlorthalidone	Chlorthalidone	44	11
Topiramate	Topiramate	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	18
Cephalexin	Cephalexin	42	34
Ibuprofen	Ibuprofen	41	17
Bupropion Xl	Bupropion Hcl	39	14
Doxycycline Hyclate	Doxycycline Hyclate	39	26
Morphine Sulfate Er	Morphine Sulfate	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Telmisartan	Telmisartan	37	suppressed
Felodipine Er	Felodipine	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	11
Glipizide Er	Glipizide	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	17
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Prednisone	Prednisone	31	21
Celecoxib	Celecoxib	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	19
Amoxicillin	Amoxicillin	29	19
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Colchicine	Colchicine	29	12
Myrbetriq	Mirabegron	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Azithromycin	Azithromycin	28	22
Lidocaine	Lidocaine	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Mounjaro	Tirzepatide	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Glipizide	Glipizide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	15
Ondansetron Odt	Ondansetron	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Diazepam	Diazepam	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Valsartan	Valsartan	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Torsemide	Torsemide	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error